Chief Operating Officer
Mr. Hackman has a bachelor of arts degree in communications from Lycoming College. Mr. Hackman has a bachelor of arts degree in communications from Lycoming College.
Jeffrey Hackman was most recently senior vice president, head of the US Internal Medicine and Oncology franchises for Shire. In this role, Mr. Hackman was a member of the US commercial leadership team and was responsible for sales, marketing, business insights and analytics for eight licensed products within Shire’s US rare disease portfolio. Prior to joining Shire, Mr. Hackman was vice president and region head for North America at Baxalta US, where he was responsible for building the oncology commercial division. Before that, Mr. Hackman was senior vice president of commercial operations, chief operating officer and board member at Sigma-Tau and Sigma-Tau Health Sciences USA. Mr. Hackman has also held senior commercial leadership positions with Intercell AG, Emergent Biosolutions, MedImmune and Sanofi Pasteur.